Short-term immunotherapy: A prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis

被引:58
|
作者
Zenner, HP
Baumgarten, C
Rasp, G
Fuchs, T
Kunkel, G
Hauswald, B
Ring, J
Effendy, I
Behrendt, W
Frosch, PJ
Przybilla, B
Brunner, FX
Merk, HF
Kapp, A
Schnitker, J
Wolf, H
机构
[1] SCHERAX ARZNEIMITTEL GMBH,D-22589 HAMBURG,GERMANY
[2] UNIV TUBINGEN,HNO KLIN,TUBINGEN,GERMANY
[3] FREE UNIV BERLIN,KLINIKUM RUDOLF VIRCHOW,ABT KLIN IMMUNOL & ASTHMAPOLIKLIN,D-1000 BERLIN,GERMANY
[4] MAXIMILIANS UNIV,KLINIKUM GROSSHADERN,HNO KLIN & POLIKLIN,MUNICH,GERMANY
[5] UNIV GOTTINGEN,HAUTKLIN,D-3400 GOTTINGEN,GERMANY
[6] MED ACAD CARL GUSTAV CARUS,HNO KLIN,DRESDEN,GERMANY
[7] TECH UNIV MUNICH,DERMATOL KLIN & POLIKLIN,D-8000 MUNICH,GERMANY
[8] KLINIKUM PHILIPPS UNIV,MED ZENTRUM HAUTKRANKHEITEN,MARBURG,GERMANY
[9] UNIV LEIPZIG,HNO KLIN,D-7010 LEIPZIG,GERMANY
[10] UNIV WITTEN HERDECKE,WITTEN,GERMANY
[11] STADT KLINIKEN,HAUTKLIN,DORTMUND,GERMANY
[12] UNIV MUNICH,DERMATOL KLIN & POLIKLIN,D-80539 MUNICH,GERMANY
[13] UNIV WURZBURG,HNO KLIN & POLIKLIN,WURZBURG,GERMANY
[14] RHEIN WESTFAL TH AACHEN,HAUTKLIN,D-5100 AACHEN,GERMANY
[15] HANNOVER MED SCH,DERMATOL KLIN & POLIKLIN,HANNOVER,GERMANY
[16] INST ANGEW STAT,BIELEFELD,GERMANY
关键词
short-term immunotherapy; specific immunotherapy; allergic rhinitis; grass pollen; rye pollen; skin prick rest; specific IgE; specific IgG4;
D O I
10.1016/S0091-6749(97)70190-8
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Short-term immunotherapy (STI) can be beneficial for patients who are noncompliant,vith long-term specific immunotherapy. Objective: The efficacy and tolerance of STI with seven pre-seasonal injections of molecular standardized allergens from grass and rye pollen has been investigated in a double-blind, placebo-controlled multicenter study with 87 patients at 12 German University hospitals. Methods: Symptoms of the eyes, nose, and bronchi and use of symptomatic drugs were documented daily in diaries by patients with allergic rhinitis to grass and/or rye pollen and without bronchial asthma. Patients were monitored by skin prick test titration and measurement of levels of specific IgE and IgG4. Results: The median nasal score for the 10 weeks with the strongest symptoms during the gross pollen season was significantly lower (p = 0.014) with 35.0 for STI (n = 41) versus 69.0 for placebo (n = 40); the overall symptom score was 54.0 for STI versus 97.5 for placebo (p = 0.020). Only STI-treated patients exposed to less than 40 pollen grains per cubic meter per week showed a significantly lower nasal symptom score of 39.0 versus 75.0 for placebo (p = 0.006); these patients also had fewer nasal symptoms and less use of topical nasal drugs (p < 0.001). The threshold dose in skin prick tests was significantly higher, being 9.06 histamine equivalent for skin prick test (HEP) for STI-treated patients who received the maximum dose (n = 22) versus 4.33 HEP for placebo (p = 0.005). Specific IgE levels were significantly higher, being 55.9 SU/ml for STI versus 393 SU/ml for placebo after seven injections (p = 0.006) and level of specific IgG4 was 5.36% for STI versus 1.28% for placebo (p < 0.001). No severe systemic reactions were observed. Conclusion: Sn with seven preseasonal injections with molecular standardized allergens is effective and well tolerated.
引用
收藏
页码:23 / 29
页数:7
相关论文
共 50 条
  • [1] DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF SPECIFIC IMMUNOTHERAPY WITH ALLERGOID IN GRASS POLLEN-INDUCED RHINITIS
    PASTORELLO, EA
    PRAVETTONI, V
    QUALIZZA, R
    CODECASA, LR
    INCORVAIA, C
    VASSELLATTI, D
    CONFALONIERI, I
    ZANUSSI, C
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1988, 81 (01) : 294 - 294
  • [2] GRASS-POLLEN IMMUNOTHERAPY - A SINGLE YEAR DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY IN PATIENTS WITH GRASS POLLEN-INDUCED ASTHMA AND RHINITIS
    ORTOLANI, C
    PASTORELLO, E
    MOSS, RB
    HSU, YP
    RESTUCCIA, M
    JOPPOLO, G
    MIADONNA, A
    CORNELLI, U
    HALPERN, G
    ZANUSSI, C
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1984, 73 (02) : 283 - 290
  • [3] Efficacy of Sublingual Swallow Immunotherapy in Children with Rye Grass Pollen Allergic Rhinitis: A Double-blind Placebo-Controlled Study
    Ahmadiafshar, Akefeh
    Maarefvand, Mina
    Taymourzade, Babak
    Mazloomzadeh, Saeedeh
    Torabi, Zohreh
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2012, 11 (02) : 175 - 181
  • [4] Grass pollen sublingual immunotherapy: A double-blind, placebo-controlled study in elderly patients with seasonal allergic rhinitis
    Bozek, Andrzej
    Kolodziejczyk, Krzysztof
    Warkocka-Szoltysek, Barbara
    Jarzab, Jerzy
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2014, 28 (05) : 423 - 427
  • [5] Double-blind, placebo-controlled study with sublingual immunotherapy in children with seasonal allergic rhinitis to grass pollen
    Wüthrich, B
    Bucher, C
    Jörg, W
    Bircher, A
    Eng, P
    Schneider, Y
    Schnyder, F
    Eigenmann, P
    Senti, G
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2003, 13 (03) : 145 - 148
  • [6] Short-term influence of Immufen™ on mild allergic rhinitis: a randomized, double-blind, placebo-controlled study
    Mamatha, K.
    Aryan, Manu Kanjoormana
    Prabhakaran, Prathibha
    Mulakal, Johannah Natinga
    Das, S. Syam
    Krishnakumar, Im
    Panicker, Sreejith Parameswara
    FRONTIERS IN ALLERGY, 2024, 5
  • [7] A Randomized Placebo-Controlled Trial of Intradermal Grass Pollen Immunotherapy for Seasonal Allergic Rhinitis
    Slovick, Anna D.
    Douiri, Abdel
    Muir, Rachel
    Guerra, Andrea
    Tsioulos, Kostas
    Haye, Evie
    Lam, Emily
    Kelly, Joanna
    Peacock, Janet
    Ying, S.
    Shamji, Mohamed H.
    Cousins, David
    Durham, Stephen R.
    Till, Stephen
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 137 (02) : AB94 - AB94
  • [8] A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL BY THE SUBLINGUAL ROUTE OF IMMUNOTHERAPY WITH A STANDARDIZED GRASS-POLLEN EXTRACT
    SABBAH, A
    HASSOUN, S
    LESELLIN, J
    ANDRE, C
    SICARD, H
    ALLERGY, 1994, 49 (05) : 309 - 313
  • [9] Epicutaneous allergen-specific immunotherapy ameliorates grass pollen-induced rhinoconjunctivitis: A double-blind, placebo-controlled dose escalation study
    Senti, Gabriela
    von Moos, Seraina
    Tay, Fabian
    Graf, Nicole
    Sonderegger, Theodor
    Johansen, Pal
    Kuendig, Thomas M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (01) : 128 - 135
  • [10] Intralymphatic immunotherapy with 2 concomitant allergens, birch and grass: A randomized, double-blind, placebo-controlled trial
    Hellkvist, Laila
    Hjalmarsson, Eric
    Georen, Susanna Kumlien
    Karlsson, Agneta
    Lundkvist, Karin
    Winqvist, Ola
    Westin, Ulla
    Cardell, Lars Olaf
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 142 (04) : 1338 - +